Manifest MedEx (MX), California's largest nonprofit health data network, announced a new initiative with California Mental Health Services Authority (CalMHSA) to support secure and appropriate data ...
Fielding grounders from Xavier Edwards. Borrowing Anthony Bender’s glove. Playing catch with Braxton Garrett. Local youth baseball players received priceless instruction from the pros at Edwards’ ...
Johnson & Johnson’s sNDA for Akeega gets US FDA approval to treat patients with BRCA2-mutated mCSPC: Horsham, Pennsylvania Wednesday, December 17, 2025, 13:00 Hrs [IST] Johnson ...
The carrier’s Connected Life platform, now available nationwide, lets AT&T customers easily set up a smart-home security ...
Graphic Packaging advances cost-cut plans and accelerates inventory actions, but trims its 2025 EBITDA and EPS outlook as production impacts mount.
FDA approves Johnson & Johnson's Akeega combo for BRCA2 metastatic prostate cancer after Phase 3 data showed major reductions in progression risk.
J. William Carpenter is an economist who writes financial topics. He is an author of published works for higher education and business clients. Doretha Clemons, Ph.D., MBA, PMP, has been a corporate ...
Ezechukwu Dan-Ekeh earned the 2025 Global Recognition Award for his effective leadership in commercial operations, strategic ...
Sydnery Mabusela was named Guard of the Year for going above and beyond to keep Lonehill safe at the Fidelity Lonehill Parade ...
From budget to smart-home integration: answer these five key questions before you commit to a home-security system for better ...
Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment ...
Innophant: Innovation Show for Young Minds Announces Regional Rounds in 16+ Cities from January 2026
Innophant, India's first-of-its-kind innovation show and movement for children and teenagers, today announced its rollout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results